SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature

Ali, Elrazi; Mohamed, Abdelaziz; Abuodeh, Joud; Albuni, Mhd Kutaiba; Al-Mannai, Najlaa; Salameh, Sarah; Petkar, Mahir; Habas, Elmukhtar

doi:10.1002/ccr3.4568

Cited by 16 publications

(12 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Unser Fall stellt die erste Publikation einer Psoriasiserythrodermie nach COVID-19-Erkrankung ohne medikamentösen Trigger dar. Die beschriebene Exazerbation der Psoriasis bei unserem vorgestellten Patienten unterstützt die aus Fallberichten und einer multizentrischen Beobachtungsstudie bekannte Hypothese, dass eine COVID-19-Infektion einen starken Trigger für eine Psoriasis darstellt [ 9 , 25 ]. Da während einer COVID-19-Erkrankung bekanntermaßen stark erhöhte Spiegel u. a. der Psoriasisschlüsselzytokine IL-17 oder auch TNF‑α gemessen werden können, mag dies eine Erklärung für eine derartige Exazerbation sein [ 13 ].…”

Section: Diskussionunclassified

“…Später wurden in einzelnen Fällen nach COVID-19-Erkrankung auch ohne medikamentösen Trigger das Auftreten einer Psoriasis guttata sowie z. B. der Übergang einer Psoriasis pustulosa vom Typ Hallopeau in eine generalisierte pustulöse Psoriasis beschrieben [ 9 , 26 , 30 ]. Dass COVID-19, wie im klinischen Alltag oft beobachtet, eine bekannte Psoriasis verschlechtern kann, wurde kürzlich mittels einer multizentrischen Beobachtungsstudie publiziert, in der es bei 23 der 358 beobachteten Psoriasispatienten (6,4 %) zu COVID-19 gekommen war [ 25 ].…”

unclassified

See 1 more Smart Citation

Erythroderme Psoriasis nach COVID-19-Erkrankung

Demiri¹,

Abdo²,

Tsianakas

2021

Hautarzt

View full text Add to dashboard Cite

Wir präsentieren einen klinischen Fall eines Patienten mit akut exazerbierter erythrodermer Plaquepsoriasis nach einer symptomatischen Infektion mit SARS-CoV‑2. Es sind bereits unterschiedliche Faktoren bekannt, die zu einer Exazerbation der Psoriasis führen können wie Medikamente oder Infektionen mit z. B. Streptokokken. Ein Zusammenhang zwischen Psoriasis und einer Infektion mit dem neuartigen Coronavirus SARS-CoV‑2 wurde v. a. in Fallberichten beschrieben, in denen eine medikamentöse Behandlung mit z. B. Hydroxychloroquin erfolgt war, ein bekannter Trigger der Psoriasis. In der Folge gab es auch einzelne Beschreibungen einer Exazerbation nach COVID-19 ohne medikamentösen Trigger, teils auch als pustulöse Psoriasisform. Unser Artikel zeigt erstmals einen Fall einer Psoriasiserythrodermie getriggert durch eine COVID-19-Erkrankung ohne offensichtlich zusätzlich medikamentösen Auslöser.

show abstract

Section: Diskussionunclassified

unclassified

Erythroderme Psoriasis nach COVID-19-Erkrankung

Demiri¹,

Abdo²,

Tsianakas

2021

Hautarzt

View full text Add to dashboard Cite

show abstract

“…The disease is more likely to be severe in patients with multiple comorbidities [ 1 , 2 ]. The presentation of SARS-CoV-2 infection is mainly with respiratory symptoms, but the involvement of other major organs like the liver, kidney, pancreas, and skin is also seen [ 3 - 5 ]. Others may present with complications like thrombosis [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study

Ali

Khamees

Abu-Tineh

et al. 2022

Cureus

View full text Add to dashboard Cite

Background and aims Coronavirus disease 2019 (COVID-19) is caused by a virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the first pandemic wave, SARS-CoV-2 had developed significant changes and mutations that resulted in the emergence of different strains. Each strain varies in its virulence and disease severity. Most reports have shown that the Omicron variant causes mild illness. Little is known about the impact of Omicron in patients with chronic myeloid leukemia. We present patients with chronic myeloid leukemia who had infection with the Omicron variant of the SARS-CoV-2 and their outcomes. Materials and methods Retrospective data from the records of the National Center for Cancer Care and Research from December 20, 2021, to January 30, 2022. Participants were adults over the age of 18 years with Omicron infection who had been diagnosed with chronic myeloid leukemia according to World Health Organization classifications from 2008 and 2016. Results Eleven patients with chronic myeloid leukemia had Omicron infection. All patients had a mild disease according to the World Health Organization classification of COVID-19 severity. The majority of patients were young males. Conclusions In patients with chronic myeloid leukemia, infection with the Omicron variant of the SARS-CoV-2 usually results in mild disease not requiring hospitalization.

show abstract

“…1 , 2 The presentation of SARS‐CoV‐2 infection is mainly with respiratory symptoms, but other major organ involvement liver, kidney, pancreas, and skin are also seen. 3 , 4 , 5 Despite the availability of protective vaccines, SARS‐CoV‐2 continued to develop mutations in the spike proteins which resulted in the emergence of new stains. Until now, there is Alfa, Beta, Gamma, Delta, and lastly, Omicron variants.…”

Section: Introductionmentioning

confidence: 99%

“…The disease severity is more pronounced in patients with comorbidities 1,2 . The presentation of SARS‐CoV‐2 infection is mainly with respiratory symptoms, but other major organ involvement liver, kidney, pancreas, and skin are also seen 3‐5 . Despite the availability of protective vaccines, SARS‐CoV‐2 continued to develop mutations in the spike proteins which resulted in the emergence of new stains.…”

Section: Introductionmentioning

confidence: 99%

SARS‐CoV‐2 omicron variant may present with severe sickle cell painful crisis: A report of two cases

Ali

Hatim

Yassin

2022

Clinical Case Reports

Self Cite

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19) is a respiratory viral illness that is caused by coronavirus 2 (SARS‐CoV‐2). The disease often presents with non‐specific symptoms such as fever, headache, and fatigue, accompanied by respiratory symptoms (e.g., cough and dyspnea) and other systemic involvement. Currently, the virus had shown significant changes and mutations that resulted in the emergence of different strains. Each strain varies in its virulence, disease severity, and the response of the body's immune system. Sickle cell disease characterized by hemolytic anemia particularly in associated with stress. Patients with sickle cell disease infected with SARS‐CoV‐2 are reported to have increased risk for hospitalization, thrombosis, and other complications compared with non‐sickle cell patients. The Omicron variant causes mild disease in general population; however, in patients with sickle cell disease, the data are limited. We present two patients known to have sickle cell disease presented with a severe acute painful crisis that required hospitalization after infection with Omicron variant of the SARS‐CoV‐2 virus.

show abstract

SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Cited by 16 publications

References 19 publications

Erythroderme Psoriasis nach COVID-19-Erkrankung

Erythroderme Psoriasis nach COVID-19-Erkrankung

SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study

SARS‐CoV‐2 omicron variant may present with severe sickle cell painful crisis: A report of two cases

Contact Info

Product

Resources

About